Daniel P. Barboriak
Professor of Radiology
(1) MR Imaging in Neuro-oncology. (2) MR Perfusion Imaging for quantitation of blood volume and permeability. (3) MR Diffusion Imaging. (4) Image Processing for Registration and Segmentation. (5) Pediatric Neuroradiology.
Current Appointments & Affiliations
- Professor of Radiology, Radiology, Neuroradiology, Radiology 2012
- Professor in Neurosurgery, Neurosurgery, Neurosurgery 2016
- Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 1996
Contact Information
- 1527 Hosp North, Durham, NC 27710
- Box 3808 Med Ctr, Durham, NC 27710
-
barbo013@mc.duke.edu
(919) 684-7407
- Background
-
Education, Training, & Certifications
- M.D., Harvard University 1986
-
Previous Appointments & Affiliations
- Professor in Pediatrics, Pediatrics, Clinical Science Departments 2012 - 2021
- Associate Professor of Radiology, Radiology, Neuroradiology, Radiology 2007 - 2011
- Associate Professor in Pediatrics, Pediatrics, Clinical Science Departments 2007 - 2011
- Associate Professor of Radiology, Radiology, Neuroradiology, Radiology 2003 - 2007
- Assistant Professor of Radiology, Radiology, Neuroradiology, Radiology 1997 - 2003
- Assistant Clinical Professor of Radiology, Radiology, Neuroradiology, Radiology 1996 - 1997
- Research
-
Selected Grants
- Improved monitoring of 2-Hydroxyglutarate to stage response of combined Vorasidenib and Tumor Specific Peptide Vaccine therapies in recurrent IDH1 mutant lower grade glioma awarded by National Institutes of Health 2022 - 2026
- NCI National Clinical Trials Network (UG1) awarded by National Institutes of Health 2019 - 2025
- ECOG-ACRIN Operations Center - Clinical Trials awarded by ECOG-ACRIN Medical Research Foundation Inc. 2015 - 2024
- Prospective Evaluation of Automated Pre- and Postoperative Tumor Segmentation for Patients with Glioblastoma awarded by Neuroradiology Education and Reserach Foundation (formerly Foundation of the ASNR) 2022 - 2023
- A Phase 1/2 Trial for Patients with Newly Diagnosed High Grade Glioma Treated with Concurrent Radiation Therapy, Temozolomide, and BMX-001 awarded by BioMimetix JV LLC 2020 - 2022
- Quantitative Staging and Therapeutic Response in IDH-1 Mutated Glioblastomas awarded by National Institutes of Health 2017 - 2021
- Ph 1/2 Trial for Patients with Newly Diagnosed High Grade Glioma Treated with Concurrent Radiation Therapy, Temozolomide, and BMX-001 awarded by BioMimetix JV LLC 2015 - 2020
- NCI National Clinical Trials Network U10 (Year 5) awarded by National Institutes of Health 2014 - 2019
- Aggregated Measures of Agreement for QIB Validation: An Open Source Toolkit awarded by Radiological Society of North America 2015 - 2017
- QIBA - Digital Reference Object for Profile DCE-MRI Analysis Software Verification 2 awarded by Radiological Society of North America 2014 - 2015
- Subcontract for ECOG-ACRIN NCORP awarded by American College of Radiology Imaging Network 2014 - 2015
- ACRIN Advanced MRI Imaging Core Lab Services Agreement awarded by American College of Radiology Imaging Network 2014 - 2015
- ACRIN Chair Agreement awarded by American College of Radiology Imaging Network 2014 - 2015
- ACRIN Advanced MRI Imaging Core Lab Services Agreement - 6684, & 6677, 6686, 6689 awarded by American College of Radiology Imaging Network 2013 - 2014
- ACRIN Chair Agreement awarded by American College of Radiology Imaging Network 2013
- ACRIN Advanced MRI Imaging Core Lab Services Agreement - 6684, & 6677, 6686, 6689 awarded by American College of Radiology Imaging Network 2012 - 2013
-
External Relationships
- American College of Radiology
- American Society of Functional Neurordiology
- American Society of Neuroradiology
- Blue Earth Diagnostics
- ECOG-ACRIN
- GE Medical Systems
- National Brain Tumor Society
- Radiological Society of North America
- Publications & Artistic Works
-
Selected Publications
-
Academic Articles
-
Boxerman, Jerrold L., Bradley S. Snyder, Daniel P. Barboriak, and Kathleen M. Schmainda. “Early post-bevacizumab change in rCBV from DSC-MRI identifies pseudoresponse in recurrent glioblastoma: Results from ACRIN 6677/RTOG 0625.” Front Oncol 13 (2023): 1061502. https://doi.org/10.3389/fonc.2023.1061502.Full Text Link to Item
-
Hendrix, Grace, Robert Benjamin, Nancie MacIver, Daniel P. Barboriak, Herbert Fuchs, and Pinar Gumus Balikcioglu. “Pediatric Giant Prolactinoma Presenting With Acute Obstructive Hydrocephalus and Intracranial Hypertension.” J Endocr Soc 5, no. 12 (December 1, 2021): bvab160. https://doi.org/10.1210/jendso/bvab160.Full Text Link to Item
-
Abu Khalaf, N., A. Desjardins, J. J. Vredenburgh, and D. P. Barboriak. “Repeatability of Automated Image Segmentation with BraTumIA in Patients with Recurrent Glioblastoma.” Ajnr Am J Neuroradiol 42, no. 6 (June 2021): 1080–86. https://doi.org/10.3174/ajnr.A7071.Full Text Link to Item
-
Schmainda, Kathleen M., Melissa A. Prah, Helga Marques, Eunhee Kim, Daniel P. Barboriak, and Jerrold L. Boxerman. “Value of dynamic contrast perfusion MRI to predict early response to bevacizumab in newly diagnosed glioblastoma: results from ACRIN 6686 multicenter trial.” Neuro Oncol 23, no. 2 (February 25, 2021): 314–23. https://doi.org/10.1093/neuonc/noaa167.Full Text Link to Item
-
Kaufmann, Timothy J., Marion Smits, Jerrold Boxerman, Raymond Huang, Daniel P. Barboriak, Michael Weller, Caroline Chung, et al. “Response to Letter to Editor.” Neuro Oncol 22, no. 11 (November 26, 2020): 1706–7. https://doi.org/10.1093/neuonc/noaa202.Full Text Link to Item
-
Boxerman, Jerrold L., Chad C. Quarles, Leland S. Hu, Bradley J. Erickson, Elizabeth R. Gerstner, Marion Smits, Timothy J. Kaufmann, et al. “Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas.” Neuro Oncol 22, no. 9 (September 29, 2020): 1262–75. https://doi.org/10.1093/neuonc/noaa141.Full Text Link to Item
-
Lui, Y. W., P. D. Chang, G. Zaharchuk, D. P. Barboriak, A. E. Flanders, M. Wintermark, C. P. Hess, and C. G. Filippi. “Artificial Intelligence in Neuroradiology: Current Status and Future Directions.” Ajnr Am J Neuroradiol 41, no. 8 (August 2020): E52–59. https://doi.org/10.3174/ajnr.A6681.Full Text Link to Item
-
Kaufmann, Timothy J., Marion Smits, Jerrold Boxerman, Raymond Huang, Daniel P. Barboriak, Michael Weller, Caroline Chung, et al. “Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases.” Neuro Oncol 22, no. 6 (June 9, 2020): 757–72. https://doi.org/10.1093/neuonc/noaa030.Full Text Link to Item
-
Schmainda, K. M., M. A. Prah, Z. Zhang, B. S. Snyder, S. D. Rand, T. R. Jensen, D. P. Barboriak, and J. L. Boxerman. “Quantitative Delta T1 (dT1) as a Replacement for Adjudicated Central Reader Analysis of Contrast-Enhancing Tumor Burden: A Subanalysis of the American College of Radiology Imaging Network 6677/Radiation Therapy Oncology Group 0625 Multicenter Brain Tumor Trial.” Ajnr Am J Neuroradiol 40, no. 7 (July 2019): 1132–39. https://doi.org/10.3174/ajnr.A6110.Full Text Link to Item
-
Barboriak, Daniel P., Zheng Zhang, Pratikkumar Desai, Bradley S. Snyder, Yair Safriel, Robert C. McKinstry, Felix Bokstein, Gregory Sorensen, Mark R. Gilbert, and Jerrold L. Boxerman. “Interreader Variability of Dynamic Contrast-enhanced MRI of Recurrent Glioblastoma: The Multicenter ACRIN 6677/RTOG 0625 Study.” Radiology 290, no. 2 (February 2019): 467–76. https://doi.org/10.1148/radiol.2019181296.Full Text Link to Item
-
Ger, R. B., A. S. R. Mohamed, M. J. Awan, Y. Ding, K. Li, X. J. Fave, A. L. Beers, et al. “Publisher Correction: A Multi-Institutional Comparison of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameter Calculations (Scientific Reports (2017) DOI: 10.1038/s41598-017-11554-w).” Scientific Reports 8, no. 1 (December 1, 2018). https://doi.org/10.1038/s41598-018-20639-z.Full Text
-
Boxerman, Jerrold L., Zheng Zhang, Yair Safriel, Jeffrey M. Rogg, Ronald L. Wolf, Suyash Mohan, Helga Marques, A Gregory Sorensen, Mark R. Gilbert, and Daniel P. Barboriak. “Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686.” Neuro Oncol 20, no. 10 (September 3, 2018): 1400–1410. https://doi.org/10.1093/neuonc/noy049.Full Text Link to Item
-
Joint Head and Neck Radiotherapy-MRI Development Cooperative, Rosalie. “Dynamic contrast-enhanced magnetic resonance imaging for head and neck cancers.” Sci Data 5 (February 13, 2018): 180008. https://doi.org/10.1038/sdata.2018.8.Full Text Link to Item
-
Ratai, Eva-Maria, Zheng Zhang, James Fink, Mark Muzi, Lucy Hanna, Erin Greco, Todd Richards, et al. “ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy.” Plos One 13, no. 6 (2018): e0198548. https://doi.org/10.1371/journal.pone.0198548.Full Text Link to Item
-
Joint Head and Neck Radiotherapy-MRI Development Cooperative, Steven E. “A Multi-Institutional Comparison of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameter Calculations.” Sci Rep 7, no. 1 (September 11, 2017): 11185. https://doi.org/10.1038/s41598-017-11554-w.Full Text Link to Item
-
Gerstner, Elizabeth R., Zheng Zhang, James R. Fink, Mark Muzi, Lucy Hanna, Erin Greco, Melissa Prah, et al. “ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI.” Clin Cancer Res 22, no. 20 (October 15, 2016): 5079–86. https://doi.org/10.1158/1078-0432.CCR-15-2529.Full Text Link to Item
-
Obuchowski, Nancy A., Andrew Buckler, Paul Kinahan, Heather Chen-Mayer, Nicholas Petrick, Daniel P. Barboriak, Jennifer Bullen, Huiman Barnhart, and Daniel C. Sullivan. “Statistical Issues in Testing Conformance with the Quantitative Imaging Biomarker Alliance (QIBA) Profile Claims.” Acad Radiol 23, no. 4 (April 2016): 496–506. https://doi.org/10.1016/j.acra.2015.12.020.Full Text Open Access Copy Link to Item
-
Sullivan, Daniel C., Nancy A. Obuchowski, Larry G. Kessler, David L. Raunig, Constantine Gatsonis, Erich P. Huang, Marina Kondratovich, et al. “Metrology Standards for Quantitative Imaging Biomarkers.” Radiology 277, no. 3 (December 2015): 813–25. https://doi.org/10.1148/radiol.2015142202.Full Text Open Access Copy Link to Item
-
Boxerman, Jerrold L., Kathleen M. Schmainda, Zheng Zhang, and Daniel P. Barboriak. “Dynamic susceptibility contrast MRI measures of relative cerebral blood volume continue to show promise as an early response marker in the setting of bevacizumab treatment.” Neuro Oncol 17, no. 11 (November 2015): 1538–39. https://doi.org/10.1093/neuonc/nov163.Full Text Link to Item
-
Goldmacher, G. V., B. M. Ellingson, J. Boxerman, D. Barboriak, W. B. Pope, and M. Gilbert. “Standardized Brain Tumor Imaging Protocol for Clinical Trials.” Ajnr Am J Neuroradiol 36, no. 10 (October 2015): E65–66. https://doi.org/10.3174/ajnr.A4544.Full Text Link to Item
-
Prah, M. A., S. M. Stufflebeam, E. S. Paulson, J. Kalpathy-Cramer, E. R. Gerstner, T. T. Batchelor, D. P. Barboriak, B. R. Rosen, and K. M. Schmainda. “Repeatability of Standardized and Normalized Relative CBV in Patients with Newly Diagnosed Glioblastoma.” Ajnr Am J Neuroradiol 36, no. 9 (September 2015): 1654–61. https://doi.org/10.3174/ajnr.A4374.Full Text Link to Item
-
Ellingson, Benjamin M., Martin Bendszus, Jerrold Boxerman, Daniel Barboriak, Bradley J. Erickson, Marion Smits, Sarah J. Nelson, et al. “Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials.” Neuro Oncol 17, no. 9 (September 2015): 1188–98. https://doi.org/10.1093/neuonc/nov095.Full Text Link to Item
-
Schmainda, Kathleen M., Zheng Zhang, Melissa Prah, Bradley S. Snyder, Mark R. Gilbert, A Gregory Sorensen, Daniel P. Barboriak, and Jerrold L. Boxerman. “Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial.” Neuro Oncol 17, no. 8 (August 2015): 1148–56. https://doi.org/10.1093/neuonc/nou364.Full Text Link to Item
-
Lin, Nancy U., Eudocia Q. Lee, Hidefumi Aoyama, Igor J. Barani, Daniel P. Barboriak, Brigitta G. Baumert, Martin Bendszus, et al. “Response assessment criteria for brain metastases: proposal from the RANO group.” Lancet Oncol 16, no. 6 (June 2015): e270–78. https://doi.org/10.1016/S1470-2045(15)70057-4.Full Text Link to Item
-
Ellingson, Benjamin M., Eunhee Kim, Davis C. Woodworth, Helga Marques, Jerrold L. Boxerman, Yair Safriel, Robert C. McKinstry, et al. “Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: a multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastoma.” Int J Oncol 46, no. 5 (May 2015): 1883–92. https://doi.org/10.3892/ijo.2015.2891.Full Text Link to Item
-
Obuchowski, Nancy A., Anthony P. Reeves, Erich P. Huang, Xiao-Feng Wang, Andrew J. Buckler, Hyun J Grace Kim, Huiman X. Barnhart, et al. “Quantitative imaging biomarkers: a review of statistical methods for computer algorithm comparisons.” Stat Methods Med Res 24, no. 1 (February 2015): 68–106. https://doi.org/10.1177/0962280214537390.Full Text Link to Item
-
Paldino, M. J., K. Hedges, K. M. Rodrigues, and D. P. Barboriak. “Repeatability of quantitative metrics derived from MR diffusion tractography in paediatric patients with epilepsy.” Br J Radiol 87, no. 1037 (May 2014): 20140095. https://doi.org/10.1259/bjr.20140095.Full Text Link to Item
-
Zhang, Jing, Daniel P. Barboriak, Hasan Hobbs, and Maciej A. Mazurowski. “A fully automatic extraction of magnetic resonance image features in glioblastoma patients.” Med Phys 41, no. 4 (April 2014): 042301. https://doi.org/10.1118/1.4866218.Full Text Link to Item
-
Boxerman, Jerrold L., Zheng Zhang, Yair Safriel, Mykol Larvie, Bradley S. Snyder, Rajan Jain, T Linda Chi, A Gregory Sorensen, Mark R. Gilbert, and Daniel P. Barboriak. “Early post-bevacizumab progression on contrast-enhanced MRI as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 Central Reader Study.” Neuro Oncol 15, no. 7 (July 2013): 945–54. https://doi.org/10.1093/neuonc/not049.Full Text Link to Item
-
Ratai, Eva-Maria, Zheng Zhang, Bradley S. Snyder, Jerrold L. Boxerman, Yair Safriel, Robert C. McKinstry, Felix Bokstein, Mark R. Gilbert, A Gregory Sorensen, and Daniel P. Barboriak. “Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677.” Neuro Oncol 15, no. 7 (July 2013): 936–44. https://doi.org/10.1093/neuonc/not044.Full Text Link to Item
-
Mansouri, Bobbak, Daniel P. Barboriak, and Ramsey K. Kilani. “Gliosarcoma metastatic to the leptomeninges and dura.” J Neuroimaging 23, no. 2 (April 2013): 245–47. https://doi.org/10.1111/j.1552-6569.2011.00641.x.Full Text Link to Item
-
Pope, Whitney B., Xin Joe Qiao, Hyun J. Kim, Albert Lai, Phioanh Nghiemphu, Xi Xue, Benjamin M. Ellingson, et al. “Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study.” J Neurooncol 108, no. 3 (July 2012): 491–98. https://doi.org/10.1007/s11060-012-0847-y.Full Text Link to Item
-
Paldino, M. J., A. Desjardins, H. S. Friedman, J. J. Vredenburgh, and D. P. Barboriak. “A change in the apparent diffusion coefficient after treatment with bevacizumab is associated with decreased survival in patients with recurrent glioblastoma multiforme.” Br J Radiol 85, no. 1012 (April 2012): 382–89. https://doi.org/10.1259/bjr/24774491.Full Text Link to Item
-
Craciunescu, Oana I., David S. Yoo, Esi Cleland, Naira Muradyan, Madeline D. Carroll, James R. MacFall, Daniel P. Barboriak, and David M. Brizel. “Dynamic contrast-enhanced MRI in head-and-neck cancer: the impact of region of interest selection on the intra- and interpatient variability of pharmacokinetic parameters.” Int J Radiat Oncol Biol Phys 82, no. 3 (March 1, 2012): e345–50. https://doi.org/10.1016/j.ijrobp.2011.05.059.Full Text Link to Item
-
Sampson, John H., Martin Brady, Raghu Raghavan, Ankit I. Mehta, Allan H. Friedman, David A. Reardon, Neil A. Petry, et al. “Colocalization of gadolinium-diethylene triamine pentaacetic acid with high-molecular-weight molecules after intracerebral convection-enhanced delivery in humans.” Neurosurgery 69, no. 3 (September 2011): 668–76. https://doi.org/10.1227/NEU.0b013e3182181ba8.Full Text Link to Item
-
Paldino, M. J., T. Z. Wong, D. A. Reardon, H. S. Friedman, and D. P. Barboriak. “Prognostic significance of parameters derived from co-registered 18F-fluorodeoxyglucose PET and contrast-enhanced MRI in patients with high-grade glioma.” Br J Radiol 84, no. 1000 (April 2011): 327–33. https://doi.org/10.1259/bjr/48528504.Full Text Link to Item
-
Port, Ruediger E., Lisa J. Bernstein, Daniel P. Barboriak, Lu Xu, Timothy P. L. Roberts, and Nicholas van Bruggen. “Noncompartmental kinetic analysis of DCE-MRI data from malignant tumors: Application to glioblastoma treated with bevacizumab.” Magn Reson Med 64, no. 2 (August 2010): 408–17. https://doi.org/10.1002/mrm.22399.Full Text Link to Item
-
Craciunescu, Oana, David Brizel, Esi Cleland, David Yoo, Naira Muradyan, Madeline Carroll, Daniel Barboriak, and James MacFall. “Dynamic contrast enhanced-MRI in head and neck cancer patients: Variability of the precontrast longitudinal relaxation time (T10).” Med Phys 37, no. 6Part1 (June 2010): 2683–92. https://doi.org/10.1118/1.3427487.Full Text Link to Item
-
Ferl, Gregory Z., Lu Xu, Michel Friesenhahn, Lisa J. Bernstein, Daniel P. Barboriak, and Ruediger E. Port. “An automated method for nonparametric kinetic analysis of clinical DCE-MRI data: application to glioblastoma treated with bevacizumab.” Magn Reson Med 63, no. 5 (May 2010): 1366–75. https://doi.org/10.1002/mrm.22335.Full Text Link to Item
-
Harreld, J. H., E. C. Smith, N. S. Prose, P. K. Puri, and D. P. Barboriak. “Trichothiodystrophy with dysmyelination and central osteosclerosis.” Ajnr Am J Neuroradiol 31, no. 1 (January 2010): 129–30. https://doi.org/10.3174/ajnr.A1665.Full Text Link to Item
-
Jackson, Edward F., Daniel P. Barboriak, Luc M. Bidaut, and Charles R. Meyer. “Magnetic resonance assessment of response to therapy: tumor change measurement, truth data and error sources.” Transl Oncol 2, no. 4 (December 2009): 211–15. https://doi.org/10.1593/tlo.09241.Full Text Link to Item
-
Meyer, Charles R., Samuel G. Armato, Charles P. Fenimore, Geoffrey McLennan, Luc M. Bidaut, Daniel P. Barboriak, Marios A. Gavrielides, et al. “Quantitative imaging to assess tumor response to therapy: common themes of measurement, truth data, and error sources.” Transl Oncol 2, no. 4 (December 2009): 198–210. https://doi.org/10.1593/tlo.09208.Full Text Link to Item
-
Barnhart, Huiman X., and Daniel P. Barboriak. “Applications of the repeatability of quantitative imaging biomarkers: a review of statistical analysis of repeat data sets.” Transl Oncol 2, no. 4 (December 2009): 231–35. https://doi.org/10.1593/tlo.09268.Full Text Link to Item
-
Hoang, J. K., E. C. Smith, and D. P. Barboriak. “Ruptured maxillary retention cyst: cause of unilateral rhinorrhea after trauma.” Ajnr Am J Neuroradiol 30, no. 6 (June 2009): 1121–22. https://doi.org/10.3174/ajnr.A1457.Full Text Link to Item
-
Paldino, M., A. Desjardins, H. S. Friedman, J. J. Vredenburgh, and D. P. Barboriak. “Prognostic significance of early changes in the apparent diffusion coefficient that occurs after treatment of patients with glioblastoma multiforme with bevacizumab.” J Clin Oncol 27, no. 15_suppl (May 20, 2009): 2058.Link to Item
-
Paldino, Michael J., Daniel Barboriak, Annick Desjardins, Henry S. Friedman, and James J. Vredenburgh. “Repeatability of quantitative parameters derived from diffusion tensor imaging in patients with glioblastoma multiforme.” J Magn Reson Imaging 29, no. 5 (May 2009): 1199–1205. https://doi.org/10.1002/jmri.21732.Full Text Link to Item
-
Paldino, Michael J., and Daniel P. Barboriak. “Fundamentals of quantitative dynamic contrast-enhanced MR imaging.” Magn Reson Imaging Clin N Am 17, no. 2 (May 2009): 277–89. https://doi.org/10.1016/j.mric.2009.01.007.Full Text Link to Item
-
Armato, S. G., C. R. Meyer, M. F. Mcnitt-Gray, G. McLennan, A. P. Reeves, B. Y. Croft, L. P. Clarke, and L. P. RIDER Research Group. “The Reference Image Database to Evaluate Response to therapy in lung cancer (RIDER) project: a resource for the development of change-analysis software.” Clin Pharmacol Ther 84, no. 4 (October 2008): 448–56. https://doi.org/10.1038/clpt.2008.161.Full Text Link to Item
-
Barboriak, Daniel P., James R. MacFall, Benjamin L. Viglianti, and Mark W. Dewhirst Dvm. “Comparison of three physiologically-based pharmacokinetic models for the prediction of contrast agent distribution measured by dynamic MR imaging.” J Magn Reson Imaging 27, no. 6 (June 2008): 1388–98. https://doi.org/10.1002/jmri.21344.Full Text Link to Item
-
Desjardins, A., D. P. Barboriak, J. E. Herndon, J. Marcello, D. A. Reardon, J. A. Quinn, J. N. Rich, S. Sathornsumetee, H. S. Friedman, and J. J. Vredenburgh. “Effect of bevacizumab (BEV) and irinotecan (CPT-11) on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in glioblastoma (GBM) patients.” Journal of Clinical Oncology 26, no. 15_suppl (May 20, 2008): 2026–2026. https://doi.org/10.1200/jco.2008.26.15_suppl.2026.Full Text
-
Provenzale, James M., Daniel P. Barboriak, Kevan VanLandingham, James MacFall, David Delong, and Darrell V. Lewis. “Hippocampal MRI signal hyperintensity after febrile status epilepticus is predictive of subsequent mesial temporal sclerosis.” Ajr Am J Roentgenol 190, no. 4 (April 2008): 976–83. https://doi.org/10.2214/AJR.07.2407.Full Text Link to Item
-
Merkle, Elmar Max, Brian Marshall Dale, and Daniel Paul Barboriak. “Gain in signal-to-noise for first-pass contrast-enhanced abdominal MR angiography at 3 Tesla over standard 1.5 Tesla: prediction with a computer model.” Acad Radiol 14, no. 7 (July 2007): 795–803. https://doi.org/10.1016/j.acra.2007.03.007.Full Text Link to Item
-
Viglianti, Benjamin L., Ana M. Ponce, Charles R. Michelich, Daohai Yu, Sheela A. Abraham, Linda Sanders, Pavel S. Yarmolenko, et al. “Chemodosimetry of in vivo tumor liposomal drug concentration using MRI.” Magn Reson Med 56, no. 5 (November 2006): 1011–18. https://doi.org/10.1002/mrm.21032.Full Text Link to Item
-
Provenzale, James M., Srinivasan Mukundan, and Daniel P. Barboriak. “Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response.” Radiology 239, no. 3 (June 2006): 632–49. https://doi.org/10.1148/radiol.2393042031.Full Text Link to Item
-
Akabani, Gamal, David A. Reardon, R Edward Coleman, Terence Z. Wong, Scott D. Metzler, James E. Bowsher, Daniel P. Barboriak, et al. “Dosimetry and radiographic analysis of 131I-labeled anti-tenascin 81C6 murine monoclonal antibody in newly diagnosed patients with malignant gliomas: a phase II study.” J Nucl Med 46, no. 6 (June 2005): 1042–51.Link to Item
-
Barboriak, Daniel P., Anthony O. Padua, Gerald E. York, and James R. Macfall. “Creation of DICOM--aware applications using ImageJ.” J Digit Imaging 18, no. 2 (June 2005): 91–99. https://doi.org/10.1007/s10278-004-1879-4.Full Text Link to Item
-
Kealey, Susan M., Todd Aho, David Delong, Daniel P. Barboriak, James M. Provenzale, and James D. Eastwood. “Assessment of apparent diffusion coefficient in normal and degenerated intervertebral lumbar disks: initial experience.” Radiology 235, no. 2 (May 2005): 569–74. https://doi.org/10.1148/radiol.2352040437.Full Text Link to Item
-
York, Gerald, Daniel Barboriak, Jeffrey Petrella, David DeLong, and James M. Provenzale. “Association of internal carotid artery injury with carotid canal fractures in patients with head trauma.” Ajr Am J Roentgenol 184, no. 5 (May 2005): 1672–78. https://doi.org/10.2214/ajr.184.5.01841672.Full Text Link to Item
-
Moya, Martin P., G Robert Delong, Daniel Barboriak, and Thomas J. Cummings. “A lethal association of congenital apnea with brainstem tegmental necrosis.” Pediatr Neurol 30, no. 3 (March 2004): 219–21. https://doi.org/10.1016/j.pediatrneurol.2003.07.007.Full Text Link to Item
-
Eastwood, James D., Michael H. Lev, Max Wintermark, Clemens Fitzek, Daniel P. Barboriak, David M. Delong, Ting-Yim Lee, et al. “Correlation of early dynamic CT perfusion imaging with whole-brain MR diffusion and perfusion imaging in acute hemispheric stroke.” Ajnr Am J Neuroradiol 24, no. 9 (October 2003): 1869–75.Link to Item
-
Barboriak, Daniel P. “Imaging of brain tumors with diffusion-weighted and diffusion tensor MR imaging.” Magn Reson Imaging Clin N Am 11, no. 3 (August 2003): 379–401. https://doi.org/10.1016/s1064-9689(03)00065-5.Full Text Link to Item
-
Rohren, Eric M., James M. Provenzale, Daniel P. Barboriak, and R Edward Coleman. “Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy.” Radiology 226, no. 1 (January 2003): 181–87. https://doi.org/10.1148/radiol.2261010920.Full Text Link to Item
-
Barboriak, Daniel P., and James M. Provenzale. “Evaluation of software for registration of contrast-enhanced brain MR images in patients with glioblastoma multiforme.” Ajr Am J Roentgenol 179, no. 1 (July 2002): 245–50. https://doi.org/10.2214/ajr.179.1.1790245.Full Text Link to Item
-
Kim, Dennis M., Stavra A. Xanthakos, Larry A. Tupler, Daniel P. Barboriak, H Cecil Charles, James R. MacFall, and K Ranga Rama Krishnan. “MR signal intensity of gray matter/white matter contrast and intracranial fat: effects of age and sex.” Psychiatry Res 114, no. 3 (July 1, 2002): 149–61. https://doi.org/10.1016/s0925-4927(02)00024-0.Full Text Link to Item
-
Barboriak, D. P., J. D. Eastwood, C. G. Barboriak, and J. M. Provenzale. “Assessment of registered serial post-contrast 3D SPGR volumetric MR imaging for evaluation of changes in brain tumors.” Radiology 222, no. 2 (February 1, 2002): 591–591.Link to Item
-
Chen, J Gene, Christopher L. Edwards, Suman Vidyarthi, Suresh Pitchumoni, Sara Tabrizi, Dan Barboriak, H Cecil Charles, and P Murali Doraiswamy. “Learning and recall in subjects at genetic risk for Alzheimer's disease.” J Neuropsychiatry Clin Neurosci 14, no. 1 (2002): 58–63. https://doi.org/10.1176/jnp.14.1.58.Full Text Link to Item
-
Eastwood, James D., Michael H. Lev, Tarek Azhari, Ting-Yim Lee, Daniel P. Barboriak, David M. Delong, Clemens Fitzek, et al. “CT perfusion scanning with deconvolution analysis: pilot study in patients with acute middle cerebral artery stroke.” Radiology 222, no. 1 (January 2002): 227–36. https://doi.org/10.1148/radiol.2221010471.Full Text Link to Item
-
Lewis, Darrell V., Daniel P. Barboriak, James R. MacFall, James M. Provenzale, Teresa V. Mitchell, and Kevan E. VanLandingham. “Do prolonged febrile seizures produce medial temporal sclerosis? Hypotheses, MRI evidence and unanswered questions.” Prog Brain Res 135 (2002): 263–78. https://doi.org/10.1016/s0079-6123(02)35025-8.Full Text Link to Item
-
Provenzale, J. M., J. R. Petrella, L. C. Cruz, J. C. Wong, S. Engelter, and D. P. Barboriak. “Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome.” Ajnr Am J Neuroradiol 22, no. 8 (September 2001): 1455–61.Link to Item
-
Barboriak, D. P., L. Lee, and J. M. Provenzale. “Serial MR imaging of pineal cysts: implications for natural history and follow-up.” Ajr Am J Roentgenol 176, no. 3 (March 2001): 737–43. https://doi.org/10.2214/ajr.176.3.1760737.Full Text Link to Item
-
Harbury, O. L., J. M. Provenzale, and D. P. Barboriak. “Vertex epidural hematomas: imaging findings and diagnostic pitfalls.” Eur J Radiol 36, no. 3 (December 2000): 150–57. https://doi.org/10.1016/s0720-048x(00)00175-3.Full Text Link to Item
-
Barboriak, D. P., T. M. Holmes, C. G. Less, R. E. Coleman, H. S. Friedman, and J. M. Provenzale. “Effect of intracavitary radiation therapy for cerebral gliomas on relative cerebral blood volume in adjacent white matter: Assessment with perfusion MR imaging.” Radiology 217 (November 1, 2000): 297–98.Link to Item
-
Rohren, E. M., D. P. Barboriak, R. E. Coleman, and J. M. Provenzale. “Detection of cerebral metastases by FDG imaging and MRI.” Radiology 217 (November 1, 2000): 498–498.Link to Item
-
Barboriak, D. P., P. M. Doraiswamy, K. R. Krishnan, S. Vidyarthi, J. Sylvester, and H. C. Charles. “Hippocampal sulcal cavities on MRI: relationship to age and apolipoprotein E genotype.” Neurology 54, no. 11 (June 13, 2000): 2150–53. https://doi.org/10.1212/wnl.54.11.2150.Full Text Link to Item
-
Provenzale, J. M., U. Ali, D. P. Barboriak, D. F. Kallmes, D. M. Delong, and R. E. McLendon. “Comparison of patient age with MR imaging features of gangliogliomas.” Ajr Am J Roentgenol 174, no. 3 (March 2000): 859–62. https://doi.org/10.2214/ajr.174.3.1740859.Full Text Link to Item
-
Chen, J. G., H. C. Charles, D. P. Barboriak, and P. M. Doraiswamy. “Magnetic resonance spectroscopy in Alzheimer's disease: focus on N-acetylaspartate.” Acta Neurol Scand Suppl 176 (2000): 20–26. https://doi.org/10.1034/j.1600-0404.2000.00303.x.Full Text Link to Item
-
Barboriak, D. P., J. R. Petrella, J. Wong, K. C. Ott, J. M. Provenzale, and J. R. MacFall. “Measurement of apparent diffusion coefficients in human brain: Comparison of three-direction isotropic and six-direction tensor methods.” Radiology 213P (November 1, 1999): 274–274.Link to Item
-
Barboriak, D. P., J. M. Provenzale, and J. R. MacFall. “White matter lesion contrast in fast spin-echo fluid-attenuated inversion recovery imaging: effect of varying effective echo time and echo train length.” Ajr Am J Roentgenol 173, no. 4 (October 1999): 1091–96. https://doi.org/10.2214/ajr.173.4.10511185.Full Text Link to Item
-
Barboriak, D. P., and J. M. Provenzale. “MR arteriography of intracranial circulation.” Ajr Am J Roentgenol 171, no. 6 (December 1998): 1469–78. https://doi.org/10.2214/ajr.171.6.9843273.Full Text Link to Item
-
Provenzale, J. M., D. P. Barboriak, and R. E. Coleman. “Limbic encephalitis: comparison of FDG PET and MR imaging findings.” Ajr Am J Roentgenol 170, no. 6 (June 1998): 1659–60. https://doi.org/10.2214/ajr.170.6.9609193.Full Text Link to Item
-
Provenzale, J. M., D. P. Barboriak, N. B. Allen, and T. L. Ortel. “Antiphospholipid antibodies: findings at arteriography.” Ajnr Am J Neuroradiol 19, no. 4 (April 1998): 611–16.Link to Item
-
Provenzale, J. M., D. P. Barboriak, I. C. Davey, and T. L. Ortel. “Cerebrovascular disease risk factors: neuroradiologic findings in patients with activated protein C resistance.” Radiology 207, no. 1 (April 1998): 85–89. https://doi.org/10.1148/radiology.207.1.9530303.Full Text Link to Item
-
Provenzale, J. M., G. J. Joseph, and D. P. Barboriak. “Dural sinus thrombosis: findings on CT and MR imaging and diagnostic pitfalls.” Ajr Am J Roentgenol 170, no. 3 (March 1998): 777–83. https://doi.org/10.2214/ajr.170.3.9490973.Full Text Link to Item
-
Provenzale, J. M., D. P. Barboriak, and T. L. Ortel. “Dural sinus thrombosis associated with activated protein C resistance: MR imaging findings and proband identification.” Ajr Am J Roentgenol 170, no. 2 (February 1998): 499–502. https://doi.org/10.2214/ajr.170.2.9456973.Full Text Link to Item
-
Provenzale, J. M., D. P. Barboriak, I. C. Davey, and T. L. Ortel. “Brain CT and MR imaging findings in patients with activated protein C resistance.” Radiology 205 (November 1, 1997): 797–797.Link to Item
-
Provenzale, J. M., and D. P. Barboriak. “Brain infarction in young adults: etiology and imaging findings.” Ajr Am J Roentgenol 169, no. 4 (October 1997): 1161–68. https://doi.org/10.2214/ajr.169.4.9308483.Full Text Link to Item
-
Barboriak, D. P., and J. M. Provenzale. “Pictorial review: magnetic resonance angiography of arterial variants at the Circle of Willis.” Clin Radiol 52, no. 6 (June 1997): 429–36. https://doi.org/10.1016/s0009-9260(97)80003-7.Full Text Link to Item
-
Provenzale, J. M., D. P. Barboriak, N. B. Allen, and T. L. Ortel. “Patients with antiphospholipid antibodies: CT and MR findings of the brain.” Ajr Am J Roentgenol 167, no. 6 (December 1996): 1573–78. https://doi.org/10.2214/ajr.167.6.8956600.Full Text Link to Item
-
PROVENZALE, J. M., D. P. BARBORIAK, and K. SIMS. “NEURORADIOLOGIC FINDINGS IN FUCOSIDOSIS, A RARE LYSOSOMAL STORAGE DISEASE.” American Journal of Neuroradiology 16, no. 4 (April 1, 1995): 809–13.Link to Item
-
Provenzale, J. M., D. P. Barboriak, and K. Sims. “Neuroradiologic findings in fucosidosis, a rare lysosomal storage disease.” Ajnr Am J Neuroradiol 16, no. 4 Suppl (April 1995): 809–13.Link to Item
-
Provenzale, J. M., D. P. Barboriak, and K. Sims. “Neuroradiologic findings in fucosidosis, a rare lysosomal storage disease.” American Journal of Neuroradiology 16, no. SUPPL. (January 1, 1995): 809–13.
-
Provenzale, J. M., D. P. Barboriak, and J. M. Taveras. “Exercise-related dissection of craniocervical arteries: CT, MR, and angiographic findings.” J Comput Assist Tomogr 19, no. 2 (1995): 268–76. https://doi.org/10.1097/00004728-199503000-00019.Full Text Link to Item
-
Provenzale, J. M., D. P. Barboriak, E. H. Gaensler, R. L. Robertson, and B. Mercer. “Lupus-related myelitis: serial MR findings.” Ajnr Am J Neuroradiol 15, no. 10 (November 1994): 1911–17.Link to Item
-
Barboriak, D. P., J. M. Provenzale, and O. B. Boyko. “MR diagnosis of Creutzfeldt-Jakob disease: significance of high signal intensity of the basal ganglia.” Ajr Am J Roentgenol 162, no. 1 (January 1994): 137–40. https://doi.org/10.2214/ajr.162.1.8273652.Full Text Link to Item
-
Barboriak, D. P., S. M. Rivitz, and F. S. Chew. “Sacral neurofibroma.” Ajr Am J Roentgenol 159, no. 3 (September 1992): 600. https://doi.org/10.2214/ajr.159.3.1503033.Full Text Link to Item
-
Chew, F. S., P. L. Smith, and D. Barboriak. “Candidal splenic abscesses.” Ajr Am J Roentgenol 156, no. 3 (March 1991): 474. https://doi.org/10.2214/ajr.156.3.1899741.Full Text Link to Item
-
-
Conference Papers
-
Cleland, E., D. Brizel, D. Yoo, M. Dolguikh, N. Muradyan, D. Barboriak, and O. Craciunescu. “SU‐GG‐J‐181: The Role of Voxel‐Based T10 Calculations in Determining Correct Pharmacokinetic Parameters for Head and Neck Tumors.” In Medical Physics, 35:2721, 2008. https://doi.org/10.1118/1.2961730.Full Text
-
Craciunescu, O., N. Muradyan, D. Barboriak, J. Macfall, and D. Brizel. “TH‐E‐M100J‐02: Potential of Dynamic Contrast Enhanced‐Magnetic Resonance Imaging (DCE‐MRI) Extracted Parameters to Estimate Treatment Response in Locally Advanced Head and Neck (LAHN) Cancer Patients.” In Medical Physics, 34:2649, 2007. https://doi.org/10.1118/1.2761755.Full Text
-
-
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.